Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-12-16

Clinical Trial Update: Indocyanine Green to Visualize Critical View of Safety During Laparoscopic Cholecystectomy for Acute Cholecystitis [Phase 4]

View source ↗

Summary

Phase 4 trial updating the use of indocyanine green to visualize the critical view of safety during laparoscopic cholecystectomy in acute cholecystitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: Hamad Medical Corporation | Conditions: Acute Cholecystitis, Acute; Cholecystitis, Choledocholithiasis | Phase 4 | Status: UNKNOWN